Robert W. Pangia, Director at BIOGEN IDEC INC. (BIIB), sold 19,000 shares at $63.93 ($1.2M) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.71 | 100 | $6K | 0.5% |
| 2 | $63.79 | 400 | $26K | 2.1% |
| 3 | $63.83 | 100 | $6K | 0.5% |
| 4 | $63.85 | 200 | $13K | 1.0% |
| 5 | $63.88 | 200 | $13K | 1.0% |
| 6 | $63.89 | 300 |
| $19K |
| 1.6% |
| 7 | $63.93 | 1,300 | $83K | 6.8% |
| 8 | $64.13 | 500 | $32K | 2.6% |
| 9 | $64.14 | 300 | $19K | 1.6% |
| 10 | $64.17 | 200 | $13K | 1.1% |
| 11 | $64.18 | 400 | $26K | 2.1% |
| 12 | $64.19 | 200 | $13K | 1.1% |
| 13 | $64.20 | 100 | $6K | 0.5% |
| 14 | $64.25 | 100 | $6K | 0.5% |
| 15 | $64.27 | 200 | $13K | 1.1% |
| 16 | $64.31 | 100 | $6K | 0.5% |
| 17 | $64.32 | 1,800 | $116K | 9.5% |
| 18 | $64.36 | 200 | $13K | 1.1% |
| 19 | $64.37 | 100 | $6K | 0.5% |
| 20 | $64.38 | 1,000 | $64K | 5.3% |
| 21 | $64.39 | 300 | $19K | 1.6% |
| 22 | $64.40 | 2,000 | $129K | 10.5% |
| 23 | $64.41 | 2,706 | $174K | 14.3% |
| 24 | $64.42 | 994 | $64K | 5.2% |
| 25 | $64.43 | 1,000 | $64K | 5.3% |
| 26 | $64.44 | 1,000 | $64K | 5.3% |
| 27 | $64.45 | 1,300 | $84K | 6.9% |
| 28 | $64.46 | 700 | $45K | 3.7% |
| 29 | $64.50 | 1,200 | $77K | 6.3% |
| Total | $64.31 avg | 19,000 | $1.2M | 100% |
| Filing → |
| BIIB | SELL | 2017-01-10 | $3.2M | — | Filing → |
| BIIB | SELL | 2015-03-11 | $1.5M | — | Filing → |
| BIIB | SELL | 2014-04-02 | $1.9M | — | Filing → |